Welcome to Novo Nordisk in the U.S. | Novo Nordisk U.S. Website
网页Learn all about Novo Nordisk in the U.S. and how we're helping to defeat diabetes, rare bleeding disorders, growth hormone-related disorders, and obesity.
Tents and sleeping bags - premium quality outdoor equipment | Nordisk
网页Nordisk is a Danish outdoor brand that specialises in tents and sleeping bags for great adventures. Nordisk produces tents ranging from small 1-person lightweight tents to large luxurious glamping tents of high quality. Nordisk has its own factory in Germany, where they produce down sleeping bags with European down.
Novo Nordisk
网页诺和诺德成立于1923年，是一家全球领先的生物制药公司，总部位于丹麦首都哥本哈根。 我们的目标是推动改变，以战胜糖尿病，和肥胖症、罕见血液疾病、内分泌紊乱等其他严重慢性疾病。
Novo Nordisk - Wikipedia
网页Novo Nordisk manufactures and markets pharmaceutical products and services, specifically diabetes care medications and devices. [5] Its main product is the drug semaglutide, used to treat diabetes under the brand names Ozempic and Rybelsus and obesity under the brand name Wegovy. [6]
Novo Nordisk | driving change to defeat serious chronic diseases
网页Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
诺和诺德 - 维基百科，自由的百科全书
网页诺和诺德（Novo Nordisk A/S、NYSE:NVO、OMX:NOVO B）是一家本部位于丹麦的制药企業。公司在糖尿病領域、生长激素領域、血友病領域提供製品和服务。
Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial
网页2024年9月11日 · Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more rapid weight loss than its popular obesity injection Wegovy.
Novo Nordisk bets $600M biobucks on NanoVation's ability to …
网页4 天之前 · Novo Nordisk's latest RNA deal involves $530M biobucks to sing in Korro's opera. Novo is paying an upfront fee of undisclosed size to enter into the collaboration. Factoring in milestones, the ...
Latest news - Novo Nordisk
网页2024年7月10日 · Our scientists are currently working on novel and innovative treatments to address the unmet needs of people living with diabetes, obesity, haemophilia, growth disorders and non-alcoholic steatohepatitis (NASH). Browse our entire R&D pipeline by study phase, or select a specific therapy areas.
News Details
网页3 天之前 · Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat serious chronic diseases, built upon our heritage in diabetes. We do so by pioneering scientific breakthroughs, expanding access to our medicines, and …